Package 0078-0372-05

{"route": ["ORAL"], "spl_id": "8f4647d0-4965-4dee-8f60-1340ef9be3de", "openfda": {"unii": ["4B3SC438HI"], "rxcui": ["1091143", "1091167", "1091182", "1091197", "1806177", "1806179", "1806183", "1806195"], "spl_set_id": ["effd952d-ac94-47bb-b107-589a4934dcca"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0372-05)", "package_ndc": "0078-0372-05", "marketing_end_date": "20261031", "marketing_start_date": "20020605"}], "brand_name": "Ritalin LA", "product_id": "0078-0372_8f4647d0-4965-4dee-8f60-1340ef9be3de", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0078-0372", "dea_schedule": "CII", "generic_name": "methylphenidate hydrochloride", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ritalin", "brand_name_suffix": "LA", "active_ingredients": [{"name": "METHYLPHENIDATE HYDROCHLORIDE", "strength": "40 mg/1"}], "application_number": "NDA021284", "marketing_category": "NDA", "marketing_end_date": "20261031", "marketing_start_date": "20020605"}